Hi Donald,
We missed you at the AGM this time…interaction would have been even better 
Kudos to Ankit and Anant for doing a in-depth and complete job….they continue to surprise with the level of detailing they have gone into.
On your query for revenue drivers – I feel that nothing major would happen till they get USFDA approval. I could see a lot of shift in focus of the company towards formulations going forward (which is a good thing) and getting the same will open up next set of opportunities on which they have been working. They have about 9 months to 1 year by which they should get approvals, any further delay may hamper their pipeline and plans.
Ankit has covered the specific answers above.
Regards,
Ayush
| Subscribe To Our Free Newsletter |
